PIIIW · P3 Health Partners Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“As of the date of this Form 10-Q, we believe that our existing cash resources are not sufficient to support planned operations for at least the next year from the issuance of the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q are issued.”View the 10-Q filed Aug 10, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $1.5B | $1.46B | $1.5BG | $1.27BG | $1.05BG | $491.06M | $145.48M | |
| -$60.79M | -$55.03M | -$22.17M | -$15.99M | -$11.4M | -$2.53M | -$2.53M | |
| — | $918K | $1.33M | $3.23M | $5.1M | $1.5M | $801.69K | |
| $115.8M | $106.31M | $112.6M | $122.36M | $157.28M | $53.39M | $36.42M | |
| $82.1M | $81.9M | $83.7M | $84.3M | $84.8M | — | — | |
| $84.15M | $84.16M | $86.06M | $86.68M | $87.29M | $795.17K | $399.18K | |
| $1.65B | $1.73B | $1.82B | $1.43B | $2.61B | $519.65M | $185.02M | |
| -$148.63M | -$270.3M | -$320.66M | -$167.93M | -$1.56B | -$28.59M | -$39.54M | |
| — | -18.53% | -21.37% | -13.26% | -148.73% | -5.82% | -27.18% | |
| -$64.48M | -$186.14M | -$234.6M | -$81.26M | -$1.47B | -$27.79M | -$39.14M | |
| -$78.62M | -$50.76M | $14.67M | -$15.8M | $1.22M | -$2.82M | -$2.44M | |
| -$227.25M | -$321.06M | -$305.99M | -$183.73M | -$1.56B | -$31.41M | -$41.97M | |
| -$10.76M | $2.03M | $4.39M | $2.7M | $1.86M | $0 | $0 | |
| -$98.44M | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -$31.41M | -$41.97M | |
| — | -10.14% | -9.05% | -4.56% | -25.74% | -6.4% | -28.85% | |
| -$118.05M | -$175.14M | -$174.53M | -$128.65M | -$1.29B | — | — | |
| — | — | — | — | -$270.13M | — | — | |
| USD/shares | -$33.01 | -$45.26 | -$46.78 | -$30.50 | -$325.00 | — | — |
| USD/shares | -$33.06 | -$45.26 | -$54.06 | -$31.50 | -$325.00 | — | — |
| shares | — | 3.27M | 2.9M | 1.9M | 831.58K | — | — |
| shares | — | 3.27M | 2.94M | 5.89M | 831.58K | — | — |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Long-term debt, including current maturities | 2026-06-30 | USD 119,854,000 | 10-Q filed 2026-08-10 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent operating lease liabilities | 2026-06-30 | USD 10,417,000 | 10-Q filed 2026-08-10 |
| Short-term borrowings | 2026-06-30 | USD 418,000 | 10-Q filed 2026-08-10 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Single Reportable Segment | $1,459,080,000 | $1,500,455,000 | $1,266,375,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Capitated Revenue | $1,428,979,000 | $1,483,602,000 | $1,252,309,000 | $1,034,800,000 | $480,739,577 | $139,332,707 | $86,465,658 |
| Health Care Patient Service | $30,101,000 | $16,853,000 | $14,066,000 | $14,671,000 | $10,323,948 | $6,149,405 | $1,231,037 |
| Health Care Incentive Fees | $16,222,000 | $356,000 | $573,000 | $238,000 | — | — | — |
| Health Care Care Coordination Management Fees | $10,823,000 | $10,563,000 | $8,301,000 | $7,924,000 | — | — | $390,600 |
| Health Care Clinical Fees Insurance Revenue | $3,056,000 | $5,934,000 | $5,192,000 | $6,158,000 | — | — | $639,636 |
| Health Care Shared Risk Revenue | — | — | $0 | $351,000 | — | — | $200,801 |
| Health Plan Name Domain | — | — | — | — | — | — | $87,696,695 |